Should have added that Gilead (GILD) has a $140 Billion market cap and it's not inconceivable that SGEN in 7-10 years can match that number...just sayin.'
SGEN worth just about $7.5 Billion right now. That price would equate to $60/share...at $35+, it may take some negotiating by Felix Baker and his crew but that's the value I put on the scientific package right now. In about 2-3 years, the price probably reaches well north of $12 Billion....so, do you want it njow or are you willing to wait and pay up later.
Of course, SGEN can do just fine on its own...in 2-3 years, the stock should be selling for $85-90....using the same metrics......and have further opportunities to grow.
I totally agree with both paladin & renmanuz regarding the confidence this management team instills in their investors. This is a very rare long term buy & hold opportunity given the current market conditions. And revenues are on the rise, which suits my personal metric(s) just fine!!
Agree completely. This management team is really top notch...and it shows on the calls. They have a great plan, even better science and we just have to be patient until they really deliver.
The Baker Brothers obviously know this company exceptionally well---it's the largest holding in their portfolio of 99 companies and their purchase of more than 1.25 MM shares for more than $45 MM over the last 2 1/2 months confirms that they like the progress they are witnessing. Felix Baker, being on the Board suggests he knows what happening; his added purchases tell me all I need to know.
Another solid quarter. I continue to be impressed with how well this company executes on its plan, and how competent and articulate their senior execs are on these CCs. It gives one, at least me, continued confidence in the future. They never make big news in these CCs, they just add some color to what has been released through either earlier data releases or annual guidance. I was interested in the fact they felt confident enough to specifically mention off label usage, something they really have stayed away from in previous calls.
Couple of million? No big deal.
What is a big deal is that SGEN is the BB's largest holding in their healthcare/biotech portfolio which holds 99 stocks....top dog out of 99: Pretty impressive...plus they recently added another large number of shares. These guys aren't stupid....so it's very significant that they deemed the company worthy enough to up their position.
What do these guys know? More than I do....but it's always a good move to follow the smart money.
Your heart is in the right place but your arithmetic is really bad. However 1+ million shares additional accumulation is a strong endorsement for those with inside vision.
Knowledge + time + science = big bucks
and spent $39,326,000 in doing so...their average price was $37.64.
I do not believe that "purchased 35 Million + Shrs during June" but please correct me if you have better data.
Yesterday wasn't bad...today is looking better. The Baker Brothers are the smart money here and they're buying...of have recently been buying heavily (now in a mandated "quiet period").
Hopefully, positive news on ongoing trials will be sufficient to prompt a 10-12% bump during the subsequent 7 days ... which might pull up the stock prices of SGen partners and some others in the sector. In anticipation I have added shares.
History has the last 7 qtr's in a row were beats. I'm thinking a repeat and an intense short squeeze with 7 days of steady increases. But then again, I am just a bit overly optimistic. There is that big pharma hunger too. I've also added at this attractive base.